Close Menu
The Cannabis Journal

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    What's Hot

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025
    X (Twitter) Instagram
    The Cannabis JournalThe Cannabis Journal Monday, October 6
    Trending
    • Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal
    • MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?
    • A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts
    • Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism
    • The Value of REITs in a Dividend Portfolio: Spotlight on AGNC, Realty Income, and VICI
    • High Tide Poised for Strong Q3 Results After August Guidance — What to Watch
    • Klarna’s NYSE Debut: Europe’s BNPL Giant Eyes U.S. Expansion Amid Investor Buzz
    • Rescheduling Hope Ignites Buzz in Cannabis Industry — But Is the Optimism Warranted?
    The Cannabis JournalThe Cannabis Journal
    • Home
    • Cannabis News
    • Stocks
    • High Tide Inc.
    • About Us
    The Cannabis Journal
    Home»Stocks»Marvell stock drops on weak data center revenue and forecast.
    Stocks

    Marvell stock drops on weak data center revenue and forecast.

    The Cannabis JournalBy The Cannabis JournalAugust 31, 2025No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    Highlights;

    • Stock Performance: Marvell’s stock fell 18% after reporting lower-than-expected data center revenue and weaker Q3 guidance.

    • Earnings Overview: Adjusted EPS of 67¢ exceeded expectations (66¢), with revenue of $2.01B matching forecasts, though data center revenue was $1.49B, below the $1.51B estimate.

    • Revenue Growth: Q2 revenue surged 58% year-over-year, a company record, driven by strong AI demand and a shift to profitability from a prior loss.

    • Future Outlook: Management expects flat Q3 data center revenue but forecasts a stronger Q4. Analysts remain cautious, noting concerns over AI growth and insufficient visibility into the customer pipeline.


    Marvell Technology Group Ltd.’s stock dropped 18% on Friday following the release of its quarterly earnings report, which showed weaker-than-expected data center revenue and underwhelming guidance for the current quarter. Here’s a summary of the key details:

    Financial Highlights:

    • Earnings per share (EPS): $0.67 adjusted (vs. $0.66 expected)
    • Revenue: $2.01 billion (in line with expectations)
    • The company reported a 58% year-over-year revenue increase in its fiscal Q2, ending August 2, driven by strong AI demand for its custom silicon and electro-optics products.
    • Net income for the quarter was $194.8 million, or $0.22 per share, compared to a net loss of $193.3 million, or $0.22 per share, in the same period last year.

    Guidance and Outlook:

    • Marvell expects Q3 revenue to be $2.06 billion, plus or minus 5%, slightly below analyst estimates of $2.11 billion.
    • CEO Matt Murphy noted that data center revenue is expected to remain flat in Q3 due to nonlinear growth in its custom AI chip business, but growth in Q4 is anticipated to be “substantially stronger.”
    • Murphy attributed the “lumpiness” in guidance to the infrastructure build-out by large hyperscalers.

    Data Center Performance:

    • Data center sales reached $1.49 billion, falling short of the $1.51 billion projected by Wall Street.
    • Some investors expressed concerns about the lack of clarity regarding the company’s pipeline of new customers, making it difficult to underwrite Marvell’s 20% data center market share target.

    Analyst Reactions:

    • Analysts at Bank of America downgraded Marvell’s stock to neutral from buy, lowering their price target to $78 per share from $90, citing concerns about AI growth prospects in the near to medium term.

    This report reflects a mixed outlook for Marvell, with strong revenue growth but challenges in meeting expectations and investor concerns about future growth prospects.



    Source: https://www.cnbc.com/2025/08/29/marvell-stock-earnings-guidance.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleTrump’s Rescheduling, Congressman’s Marijuana Bill Highlight CBT’s Top August Stories
    Next Article Dutchie Unveils Advanced E-Commerce Platform and Certification Program for Partners
    The Cannabis Journal
    • Website

    Related Posts

    Cannabis News

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025
    Companies

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025
    Cannabis News

    Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism

    September 17, 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Latest

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 20255 Views

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 20252 Views

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 20251 Views

    Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism

    September 17, 20255 Views
    Stay In Touch
    • Twitter
    • Instagram

    Subscribe to Updates

    Get the latest tech news from The Cannabis Journal.

    Most Popular

    High Tide Surges Ahead as Integrity and Scale Define Industry Leadership

    September 4, 20259 Views

    Tilray Stock: Stunning 5x Growth Potential Revealed

    August 26, 20258 Views

    German Retail Acquisition Pending for High Tide – New Cannabis Ventures

    August 21, 20258 Views
    Our Picks

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.

    Ad Blocker Enabled!
    Ad Blocker Enabled!
    To make it possible to run this website, we would love to show you some ads! Please <3 Thanks - The Cannabis Journal